about
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growthHuman fibroblast growth factor 1 gene expression in vascular smooth muscle cells is modulated via an alternate promoter in response to serum and phorbol esterHuman vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor)Human smooth muscle VLA-1 integrin: purification, substrate specificity, localization in aorta, and expression during developmentInflammation and metabolic dysfunction: links to cardiovascular diseasesA p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain geneMyosin heavy chain gene expression in normal and hyperplastic human prostate tissueRestricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cellsCell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells.Synergistic increase in nerve growth factor secretion by cultured vascular smooth muscle cells treated with injury-related growth factors.Molecular control of vascular smooth muscle cell differentiation.6A3-5/Osa2 is an early activated gene implicated in the control of vascular smooth muscle cell functions.Characterization of the atherosclerotic plaque in the internal mammary artery.Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells.Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression.Molecular mechanisms in intimal hyperplasia.Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor.Microfluidic techniques for development of 3D vascularized tissueH19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury.Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes.Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury modelProduction of transforming growth factor beta 1 during repair of arterial injury.Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heartVEGF receptors mediate hypoxic remodeling of adult ovine carotid arteries.Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation.MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migrationAugmented cell cycle protein expression and kinase activity in atherosclerotic rabbit vessels.Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridizationNitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Human coronary artery smooth muscle cell responses to bioactive polyelectrolyte multilayer interfaces.The nuclear autoantigen CENP-B displays cytokine-like activities toward vascular smooth muscle cells.Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat.Mammalian nonsarcomeric myosin regulatory light chains are encoded by two differentially regulated and linked genes.Pipoxolan ameliorates cerebral ischemia via inhibition of neuronal apoptosis and intimal hyperplasia through attenuation of VSMC migration and modulation of matrix metalloproteinase-2/9 and Ras/MEK/ERK signaling pathwaysRole of heme in cardiovascular physiology and disease.Phenotypic modulation of primary vascular smooth muscle cells by short-term culture on micropatterned substrate.The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.Ischemia: reperfusion injury and restenosis after coronary angioplasty.
P2860
Q24563508-8320FA8C-FDCF-4763-90E5-48F74A3DBC2DQ24630121-AFF2AB98-DAA3-4370-9F92-11EA1FFF4658Q24634292-4C3B7C21-F5A3-4EEB-A3BC-0CC2FEF68701Q24678731-3CC44CC4-25E2-4A64-B8BD-1DF6B3ED604CQ26851186-287892BE-2661-4D1C-A978-6E5936B9CF88Q28138161-B01304D4-57AF-4E86-A8DD-25BBAEB3FC6BQ28141527-6138B699-997C-4402-A75C-DE8144919EA8Q28273856-CAA8621F-FB7F-4829-8AF8-22A786D2183DQ30442323-512080FC-CA13-4CB0-8A8D-F62134F02491Q30470066-F7095501-49F5-4011-8774-1CF479920CD1Q30473015-DADB237B-4BA0-4CE2-BE88-D2D29F444FF9Q31111995-8ED8CEA2-BA91-42B9-9230-12EB764CCA23Q32066863-643C35C6-EBB0-4102-B1C0-988BB5E21E2CQ33557153-D285CE61-4096-43B7-AB31-B27348D7F9A3Q33564406-4206FC2C-CC38-4B2C-8D63-5A45F5A744C4Q33661435-8771FE26-1C5B-49DE-8584-BD5B72D351ECQ33685386-4BF54EBD-9E44-44FB-AE81-F97BD8EB0E07Q33843561-0E3032D7-2B86-4436-8310-B0B9098831D2Q33902104-D43D9C09-FDCE-4366-8F6A-31DCBEB362E8Q33987560-23FAFB54-097E-4262-AD27-A2FA032411A2Q34120927-07BEEC8A-8EB1-4F66-BF0E-C36139BED32EQ34125214-65C9AD2E-E0E8-4EC8-98E0-1EFA14637FDDQ34150085-1E78FE71-D982-4D9E-8832-0543455B34CCQ34198234-DAD1C224-42DB-4C34-9D54-10AA8FA794B9Q34246883-08E6C823-A223-4E71-B25E-98AFB753D9B3Q34295320-E474269F-C27D-42ED-979D-21FA3BB736F0Q34373712-61A85718-0901-4748-B2A7-E494CCC3040AQ34426103-5AB64119-C425-463F-8554-9A8868A8F844Q34467100-1C77B513-0CBB-47CB-8E6B-B804478E50DEQ34563319-5EC8CB95-6C3E-4717-A7E5-D641B0E72748Q34573717-B2FB3F4F-82DA-4357-9858-A23EF208D7FBQ34591386-A5760C03-AB1E-4CAC-8C23-10F54E782480Q34707690-BE2B0BCE-928F-4A03-B5CB-20432737702CQ34793220-16BF4759-76CA-467E-AC2B-F1231C496746Q34892124-FE17C8EE-F002-4E78-B8C3-D42501AB7B17Q35005859-766F5AAA-9BF5-41B3-904D-8DBD08DC6AF2Q35088049-3BDE8012-5EFA-46B4-BA59-08DC939192D4Q35088489-0731D184-745D-4D2E-B3DA-B21728060F7AQ35425744-6AB842DA-C876-44FD-831E-AADB4FA2AF0BQ35534523-35BEA13C-4EFE-4C9D-BBC8-A7E6C42556DD
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Replication of smooth muscle cells in vascular disease.
@en
Replication of smooth muscle cells in vascular disease.
@nl
type
label
Replication of smooth muscle cells in vascular disease.
@en
Replication of smooth muscle cells in vascular disease.
@nl
prefLabel
Replication of smooth muscle cells in vascular disease.
@en
Replication of smooth muscle cells in vascular disease.
@nl
P2093
P356
P1433
P1476
Replication of smooth muscle cells in vascular disease.
@en
P2093
Campbell GR
Campbell JH
Schwartz SM
P304
P356
10.1161/01.RES.58.4.427
P577
1986-04-01T00:00:00Z